Cebrero-Cangueiro, T., Álvarez-Marín, R., Labrador-Herrera, G., Smani, Y., Cordero-Matía, E., Pachón, J., & Pachón-Ibáñez, M. E. (2018). In vitro Activity of Pentamidine Alone and in Combination With Aminoglycosides, Tigecycline, Rifampicin, and Doripenem Against Clinical Strains of Carbapenemase-Producing and/or Colistin-Resistant Enterobacteriaceae. Front Cell Infect Microbiol.
Citação norma ChicagoCebrero-Cangueiro, Tania, Rocío Álvarez-Marín, Gema Labrador-Herrera, Younes Smani, Elisa Cordero-Matía, Jerónimo Pachón, and María Eugenia Pachón-Ibáñez. "In Vitro Activity of Pentamidine Alone and in Combination With Aminoglycosides, Tigecycline, Rifampicin, and Doripenem Against Clinical Strains of Carbapenemase-Producing And/or Colistin-Resistant Enterobacteriaceae." Front Cell Infect Microbiol 2018.
MLA citiranjeCebrero-Cangueiro, Tania, et al. "In Vitro Activity of Pentamidine Alone and in Combination With Aminoglycosides, Tigecycline, Rifampicin, and Doripenem Against Clinical Strains of Carbapenemase-Producing And/or Colistin-Resistant Enterobacteriaceae." Front Cell Infect Microbiol 2018.